143 related articles for article (PubMed ID: 37255476)
21. Aromatase is a direct target of FOXL2: C134W in granulosa cell tumors via a single highly conserved binding site in the ovarian specific promoter.
Fleming NI; Knower KC; Lazarus KA; Fuller PJ; Simpson ER; Clyne CD
PLoS One; 2010 Dec; 5(12):e14389. PubMed ID: 21188138
[TBL] [Abstract][Full Text] [Related]
22. Malignant Sex Cord-Stromal Tumor, Not Otherwise Specified, Harboring FOXL2, p53, and TERT Promoter Mutations: Report of a Case.
Mayer R; Dandulakis M; Richards S; Roque DM; Staats PN
Int J Gynecol Pathol; 2020 Nov; 39(6):567-572. PubMed ID: 31789679
[TBL] [Abstract][Full Text] [Related]
23. Impact of FOXL2 mutations on signaling in ovarian granulosa cell tumors.
Leung DTH; Fuller PJ; Chu S
Int J Biochem Cell Biol; 2016 Mar; 72():51-54. PubMed ID: 26791928
[TBL] [Abstract][Full Text] [Related]
24. Absence of a FOXL2 mutation (402C→G) in the blood of adult-type granulosa cell tumor patients possessing the FOXL2 mutation.
Lee S; Kim TH; Won M; Ko JJ; Rho J; Lee K; Bae J
Int J Gynecol Cancer; 2010 Nov; 20(8):1341-3. PubMed ID: 21051974
[TBL] [Abstract][Full Text] [Related]
25. FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines.
Kommoss S; Anglesio MS; Mackenzie R; Yang W; Senz J; Ho J; Bell L; Lee S; Lorette J; Huntsman DG; Blake Gilks C
Mod Pathol; 2013 Jun; 26(6):860-7. PubMed ID: 23348906
[TBL] [Abstract][Full Text] [Related]
26. FOXL2 Mutation Status in Granulosa Theca Cell Tumors of the Ovary.
Nolan A; Joseph NM; Sangoi AR; Rabban J; Zaloudek C; Garg K
Int J Gynecol Pathol; 2017 Nov; 36(6):568-574. PubMed ID: 28319575
[TBL] [Abstract][Full Text] [Related]
27. FOXO1 mitigates the SMAD3/FOXL2
Secchi C; Benaglio P; Mulas F; Belli M; Stupack D; Shimasaki S
J Transl Med; 2021 Feb; 19(1):90. PubMed ID: 33639972
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of molecular analysis in challenging ovarian sex cord-stromal tumours: a review of 50 cases.
Stewart CJR; Amanuel B; De Kock L; Apellaniz-Ruiz M; Carrello A; Giardina T; Grieu-Iacopetta F; Thomas MA; Foulkes WD
Pathology; 2020 Oct; 52(6):686-693. PubMed ID: 32782216
[TBL] [Abstract][Full Text] [Related]
29. Ovarian cellular fibromas lack FOXL2 mutations: a useful diagnostic adjunct in the distinction from diffuse adult granulosa cell tumor.
McCluggage WG; Singh N; Kommoss S; Huntsman DG; Gilks CB
Am J Surg Pathol; 2013 Sep; 37(9):1450-5. PubMed ID: 23774170
[TBL] [Abstract][Full Text] [Related]
30. Mutational analysis of FOXL2 p.C134W and expression of bone morphogenetic protein 2 in Japanese patients with granulosa cell tumor of ovary.
Oseto K; Suzumori N; Nishikawa R; Nishikawa H; Arakawa A; Ozaki Y; Asai H; Kawai M; Mizuno K; Takahashi S; Shirai T; Yamada-Namikawa C; Nakanishi M; Kajiyama H; Kikkawa F; Sugiura-Ogasawara M
J Obstet Gynaecol Res; 2014 May; 40(5):1197-204. PubMed ID: 24689977
[TBL] [Abstract][Full Text] [Related]
31. Cytologic features of sex cord-stromal tumors in women.
Edmund LN; Salama AM; Murali R
Cancer Cytopathol; 2022 Jan; 130(1):55-71. PubMed ID: 34411449
[TBL] [Abstract][Full Text] [Related]
32. The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumors.
Schrader KA; Gorbatcheva B; Senz J; Heravi-Moussavi A; Melnyk N; Salamanca C; Maines-Bandiera S; Cooke SL; Leung P; Brenton JD; Gilks CB; Monahan J; Huntsman DG
PLoS One; 2009 Nov; 4(11):e7988. PubMed ID: 19956657
[TBL] [Abstract][Full Text] [Related]
33. FOXL2
Fuller PJ; Nguyen T; Alexiadis M; Chu S
J Pathol; 2022 Jan; 256(1):1-3. PubMed ID: 34687235
[TBL] [Abstract][Full Text] [Related]
34. FOXL2, GATA4, and SMAD3 co-operatively modulate gene expression, cell viability and apoptosis in ovarian granulosa cell tumor cells.
Anttonen M; Pihlajoki M; Andersson N; Georges A; L'hôte D; Vattulainen S; Färkkilä A; Unkila-Kallio L; Veitia RA; Heikinheimo M
PLoS One; 2014; 9(1):e85545. PubMed ID: 24416423
[TBL] [Abstract][Full Text] [Related]
35. The Pathognomonic FOXL2 C134W Mutation Alters DNA-Binding Specificity.
Carles A; Trigo-Gonzalez G; Cao Q; Cheng SG; Moksa M; Bilenky M; Huntsman DG; Morin GB; Hirst M
Cancer Res; 2020 Sep; 80(17):3480-3491. PubMed ID: 32641414
[TBL] [Abstract][Full Text] [Related]
36. Mutant FOXL2
Weis-Banke SE; Lerdrup M; Kleine-Kohlbrecher D; Mohammad F; Sidoli S; Jensen ON; Yanase T; Nakamura T; Iwase A; Stylianou A; Abu-Rustum NR; Aghajanian C; Soslow R; Da Cruz Paula A; Koche RP; Weigelt B; Christensen J; Helin K; Cloos PAC
Cancer Res; 2020 Sep; 80(17):3466-3479. PubMed ID: 32641411
[TBL] [Abstract][Full Text] [Related]
37. Mutational analysis of FOXL2 codon 134 in granulosa cell tumour of ovary and other human cancers.
Kim MS; Hur SY; Yoo NJ; Lee SH
J Pathol; 2010 Jun; 221(2):147-52. PubMed ID: 20198651
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of FOXL2 mutation and mRNA expression in adult and juvenile granulosa cell tumors of the ovary.
D'Angelo E; Mozos A; Nakayama D; Espinosa I; Catasus L; Muñoz J; Prat J
Mod Pathol; 2011 Oct; 24(10):1360-7. PubMed ID: 21623383
[TBL] [Abstract][Full Text] [Related]
39. FOXL2 mutation is absent in uterine tumors resembling ovarian sex cord tumors.
Chiang S; Staats PN; Senz J; Kommoss F; De Nictolis M; Huntsman DG; Gilks CB; Oliva E
Am J Surg Pathol; 2015 May; 39(5):618-23. PubMed ID: 25581731
[TBL] [Abstract][Full Text] [Related]
40. FOXL2 and TERT promoter mutation detection in circulating tumor DNA of adult granulosa cell tumors as biomarker for disease monitoring.
Groeneweg JW; Roze JF; Peters EDJ; Sereno F; Brink AGJ; Paijens ST; Nijman HW; van Meurs HS; van Lonkhuijzen LRCW; Piek JMJ; Lok CAR; Monroe GR; van Haaften GW; Zweemer RP
Gynecol Oncol; 2021 Aug; 162(2):413-420. PubMed ID: 34083028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
